Skip to main content
Fig. 5 | Renal Replacement Therapy

Fig. 5

From: Suppression of platelet reactivity during dialysis by addition of a nitric oxide donor to the dialysis fluid

Fig. 5

The level of cGMP in the platelets. The platelet cGMP levels were measured when the PS membrane dialyzer was used (n = 6). The gray bar denotes the NO (−) condition, and the black bar denotes the NO (+) condition. There was no significant difference in the platelet cGMP levels between the two conditions at the start of dialysis. However, 30 min after the start of dialysis, significant increase of the level of cGMP in the platelets was observed in the NO (+) condition as compared to the NO (−) condition (P < 0.05). This difference between the two groups was sustained even until 240 min after the start of dialysis (P < 0.05)

Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us